Nanomedicine targets iron metabolism for cancer therapy
Open Access
- 28 December 2021
- journal article
- review article
- Published by Wiley in Cancer Science
- Vol. 113 (3) , 828-837
Abstract
Iron is an essential element for cell proliferation and homeostasis via engaging in cell metabolism including DNA synthesis, cell cycle, and redox cycling, while iron overload may contribute to tumor initiation, proliferation, metastasis, and angiogenesis. Therefore, manipulating iron metabolisms, such as using iron chelators, transferrin receptor 1 (TFR1) antibodies, and cytotoxic ligands conjugated to transferrin, has become a considera.Keywords
Funding Information
- National Natural Science Foundation of China (31820103004, 321171370)
This publication has 73 references indexed in Scilit:
- Iron Metabolism Regulates p53 Signaling through Direct Heme-p53 Interaction and Modulation of p53 Localization, Stability, and FunctionCell Reports, 2014
- The Presence of Mucosal Iron in the Fallopian Tube Supports the “Incessant Menstruation Hypothesis” for Ovarian CarcinomaInternational Journal of Gynecological Pathology, 2013
- Iron Chelation in the Treatment of Cancer: A New Role for Deferasirox?The Journal of Clinical Pharmacology, 2013
- Iron chelation: a potential therapeutic strategy in oesophageal cancerBritish Journal of Pharmacology, 2013
- Development of Human Single-Chain Antibodies to the Transferrin Receptor that Effectively Antagonize the Growth of Leukemias and LymphomasCancer Research, 2010
- Effect of pH on Fenton and Fenton‐like oxidationEnvironmental Technology, 2009
- Contents of Endometriotic Cysts, Especially the High Concentration of Free Iron, Are a Possible Cause of Carcinogenesis in the Cysts through the Iron-Induced Persistent Oxidative StressClinical Cancer Research, 2008
- Hepatic Iron Overload Induces Hepatocellular Carcinoma in Transgenic Mice Expressing the Hepatitis C Virus PolyproteinGastroenterology, 2006
- The Nfs1 interacting protein Isd11 has an essential role in Fe/S cluster biogenesis in mitochondriaThe EMBO Journal, 2005
- Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1, but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulationCarcinogenesis, 2003